21 citations
,
November 1981 in “Archives of Dermatology” This study hypothesizes that postinflammatory hyperpigmentation in ashy dermatosis may result from basal cell apoptosis, as evidenced by consistent histologic findings across nine patients.
8 citations
,
February 2020 in “Fertility and Sterility” This study discusses treatment approaches for refractory Asherman syndrome, highlighting the potential role of CD133+ bone marrow-derived stem cells in conjunction with hysteroscopy for endometrial regeneration and improved pregnancy outcomes.
5 citations
,
September 2012 in “BMJ case reports” This case study reports that a woman with non-classical adrenal hyperplasia who self-treated with Ashwagandha for six months experienced biochemical improvements and reduced scalp hair loss.
2 citations
,
January 2017 in “Case reports in endocrinology” This report describes an elderly woman whose nonclassic 11-hydroxylase deficiency, presenting as acne and male pattern alopecia, may have been ameliorated by Ashwagandha root in a dose-related manner.
1 citations
,
July 2022 in “The journal of investigative dermatology/Journal of investigative dermatology” This study found that Ashwagandha-derived nanovesicles increased cell proliferation, angiogenesis, and growth factor expression in vitro, suggesting they may have potential as a plant-based alternative or complement to current therapies for hair and skin conditions.
1 citations
,
June 2022 in “INDIAN JOURNAL OF APPLIED RESEARCH” This review compiles existing knowledge on ashwagandha's potential to stimulate hair growth but reports no new experimental findings, emphasizing its medicinal properties and usage in Ayurvedic medicine.
July 2026 in “Experimental Dermatology” This study found that Ashwagandha-derived exosome-like nanovesicles promoted hair growth in several preclinical models and may offer a novel non-drug strategy to reduce hair shedding.
July 2024 in “Journal of Investigative Dermatology” Ashwagandha nanoparticles help hair grow by increasing a growth factor.
September 2023 in “Journal of Nutrition and Metabolism” This study found that the ashwagandha extracts ASH-Ext1 and ASH-Ext2 show different pharmacological activities in cell models due to their distinct withanolide proportions, highlighting the need for standardized extraction protocols to ensure consistent therapeutic efficacy.
Ashwagandha-derived nanoparticles can promote human hair growth.
April 2023 in “Journal of Investigative Dermatology” This study examined Ashwagandha-derived exosome-like nanoparticles and found that they increased hair growth markers and hair shaft production in human hair follicles ex vivo, suggesting potential for plant-derived exosome therapies in hair loss treatments.
April 2012 in “Journal of the American Academy of Dermatology” Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this research, lipidomic, proteomic, and metabolomic analyses of exosomes from seven Ashwagandha seed batches revealed that Ashwagandha-derived exosome-like nanovesicles can up-regulate VEGF-A production and promote hair growth in human models tested outside the body.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers conducted a comprehensive analysis of seven Ashwagandha seed exosome lots and found that treatment with these exosome-like nanovesicles can up-regulate VEGF-A production and promote human hair growth in an ex vivo model.
This study found that Ashwagandha root extract significantly improved skin and hair quality in healthy adults with hair loss or skin conditions over 75 days compared to placebo.
This study reported that an Ayurveda-based regimen of Guduchi, Ashwagandha, and Curcumin may safely improve quality of life, including physical and emotional functioning, in breast cancer patients receiving conventional therapy, with no serious adverse events over an 8-week period.
September 2025 in “Australian Journal of Herbal and Naturopathic Medicine” This review reported that Withania somnifera (Ashwagandha) significantly improved symptoms like vasomotor disturbances, psychological well-being, and sleep quality in perimenopausal women and was well tolerated, with largely mild side effects in examined trials.
July 2025 in “SKIN The Journal of Cutaneous Medicine” This review examined the dermatological potential of Withania somnifera (Ashwagandha) and found preliminary evidence of its beneficial effects on various non-malignant skin conditions, such as pigmentary disorders, inflammatory skin issues, wound healing, and scalp health, though further research is needed to confirm these findings.
April 2024 in “The journal of investigative dermatology/Journal of investigative dermatology” In this mouse model study, researchers found that deleting the ASH2L gene in epidermal progenitor cells led to thinner epidermal layers, delayed hair follicle development, and reduced epidermal stem cell pools, with alterations in genes related to hair follicle development and the Notch signaling pathway.
January 2022 in “Journal for ReAttach Therapy and Developmental Diversities” This study suggests that an Ayurveda-based regimen including Guduchi, Ashwagandha, and Curcumin may enhance quality of life and is safe for breast cancer patients receiving conventional therapy.
15 citations
,
August 2015 in “Scanning” This study suggests that corkscrew hairs in tinea capitis result from internal hair damage by Trichophyton violaceum and external resistance from scalp scales.
6 citations
,
July 1994 in “Journal of Dermatological Science” This study found that introducing the recombinant rat OTC gene into SPF-ASH mice restored normal hair growth and metabolic function, improving symptoms associated with OTC deficiency.
This case report describes folliculitis as a rare side effect in a 37-year-old woman using acitretin for pustular psoriasis, suggesting it should be considered in differential diagnoses for similar eruptions.
January 2026 in “International journal of research and scientific innovation” This study reviewed a traditional siddha hair treatment using quail bone ash and sesame oil, observing reduced hair fall and stimulation of new growth, though it suggests further scientific and clinical validation is needed for these findings.
In this study, introducing the rat OTC gene into spf-ash mice led to increased OTC activity and normalized hair growth and biochemical markers like urinary orotic acid and serum citrulline, partially correcting the symptoms of OTC deficiency.
March 1997 in “Hair transplant forum international” This abstract reports on the 1997 meeting of the American Society of Hair Restoration Surgeons and the American Academy of Cosmetic Surgery, and it contains no new research findings.
14 citations
,
February 1991 in “FEBS Letters” This study found that introducing rat ornithine transcarbamylase gene into spf-ash mice improved liver and intestinal enzyme activity and normalized some metabolic indicators.
6 citations
,
February 2023 in “Cosmetics” This study found that hexane extracts of Nostoc verrucosum significantly inhibited melanin synthesis in melanoma cells and demonstrated antioxidant activity, suggesting potential use in developing cosmetic and functional food products.
May 2015 in “Hair transplant forum international” This article discusses the American Society of Hair Restoration Surgery (ASHRS) but does not present new research findings.
January 1995 in “Hair transplant forum international” This article describes the inaugural meeting of the ASHRS, detailing its organization and schedule, but reports no research findings.